Cargando…
IVIG Treatment and Prognosis in Guillain–Barré Syndrome
INTRODUCTION: Guillain–Barré syndrome (GBS) is an acute, immune-mediated polyneuropathy that often leads to severe weakness. Intravenous immunoglobulin (IVIG) is a proven effective treatment for GBS (class 1 evidence). However, about 25% of patients need artificial ventilation and 20% are still unab...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883091/ https://www.ncbi.nlm.nih.gov/pubmed/20396937 http://dx.doi.org/10.1007/s10875-010-9407-4 |